Skip to main content

Table 1 Patient demographics

From: Structural effects of sprifermin in knee osteoarthritis: a post-hoc analysis on cartilage and non-cartilaginous tissue alterations in a randomized controlled trial

  100 μg group
(n = 57)
Matched placebo group
(n = 18)
Age, mean (standard deviation) 61.2 (9.1) 60.9 (6.9)
Sex, no. (%) female 39 (68.4) 12 (66.7)
Body mass index (standard deviation) 30.5 (5.0) 31.5 (5.3)
Kellgren-Lawrence grade 3 (%) 29 (50.9) 11 (61.1)
Time since onset of osteoarthritis, years (standard deviation) 7.1 (5.4) 7.4 (3.7)